Ignite Creation Date:
2025-12-25 @ 2:04 AM
Ignite Modification Date:
2026-03-05 @ 5:40 PM
Study NCT ID:
NCT04590560
Status:
RECRUITING
Last Update Posted:
2024-12-09
First Post:
2020-10-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
What is the Best Interval to Screen Women 45-49 and 70-74 for Breast Cancer?
Sponsor:
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IRST174.22
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None